These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 26078337)
1. Identification and characterization of RET fusions in advanced colorectal cancer. Le Rolle AF; Klempner SJ; Garrett CR; Seery T; Sanford EM; Balasubramanian S; Ross JS; Stephens PJ; Miller VA; Ali SM; Chiu VK Oncotarget; 2015 Oct; 6(30):28929-37. PubMed ID: 26078337 [TBL] [Abstract][Full Text] [Related]
2. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases. Skálová A; Vanecek T; Uro-Coste E; Bishop JA; Weinreb I; Thompson LDR; de Sanctis S; Schiavo-Lena M; Laco J; Badoual C; Santana Conceiçao T; Ptáková N; Baněčkova M; Miesbauerová M; Michal M Am J Surg Pathol; 2018 Nov; 42(11):1445-1455. PubMed ID: 30045065 [TBL] [Abstract][Full Text] [Related]
3. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct? Skálová A; Ptáková N; Santana T; Agaimy A; Ihrler S; Uro-Coste E; Thompson LDR; Bishop JA; Baněčkova M; Rupp NJ; Morbini P; de Sanctis S; Schiavo-Lena M; Vanecek T; Michal M; Leivo I Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284 [TBL] [Abstract][Full Text] [Related]
4. RET rearrangements are actionable alterations in breast cancer. Paratala BS; Chung JH; Williams CB; Yilmazel B; Petrosky W; Williams K; Schrock AB; Gay LM; Lee E; Dolfi SC; Pham K; Lin S; Yao M; Kulkarni A; DiClemente F; Liu C; Rodriguez-Rodriguez L; Ganesan S; Ross JS; Ali SM; Leyland-Jones B; Hirshfield KM Nat Commun; 2018 Nov; 9(1):4821. PubMed ID: 30446652 [TBL] [Abstract][Full Text] [Related]
5. Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models. Okamoto K; Kodama K; Takase K; Sugi NH; Yamamoto Y; Iwata M; Tsuruoka A Cancer Lett; 2013 Oct; 340(1):97-103. PubMed ID: 23856031 [TBL] [Abstract][Full Text] [Related]
10. Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo. Suzuki M; Makinoshima H; Matsumoto S; Suzuki A; Mimaki S; Matsushima K; Yoh K; Goto K; Suzuki Y; Ishii G; Ochiai A; Tsuta K; Shibata T; Kohno T; Esumi H; Tsuchihara K Cancer Sci; 2013 Jul; 104(7):896-903. PubMed ID: 23578175 [TBL] [Abstract][Full Text] [Related]
11. Identification of RET fusions in a Chinese multicancer retrospective analysis by next-generation sequencing. Shi M; Wang W; Zhang J; Li B; Lv D; Wang D; Wang S; Cheng D; Ma T Cancer Sci; 2022 Jan; 113(1):308-318. PubMed ID: 34710947 [TBL] [Abstract][Full Text] [Related]
12. Spindle Cell Tumors With RET Gene Fusions Exhibit a Morphologic Spectrum Akin to Tumors With NTRK Gene Fusions. Antonescu CR; Dickson BC; Swanson D; Zhang L; Sung YS; Kao YC; Chang WC; Ran L; Pappo A; Bahrami A; Chi P; Fletcher CD Am J Surg Pathol; 2019 Oct; 43(10):1384-1391. PubMed ID: 31219820 [TBL] [Abstract][Full Text] [Related]
13. Concurrent KRAS p.G12C mutation and ANK3::RET fusion in a patient with metastatic colorectal cancer: a case report. Bedau T; Heydt C; Siebolts U; Zander T; Kraemer M; Loeser H; Buettner R; Quaas A Diagn Pathol; 2024 Mar; 19(1):55. PubMed ID: 38539256 [TBL] [Abstract][Full Text] [Related]
14. Correlation between DPYD gene variation and KRAS wild type status in colorectal cancer. Kleist B; Kempa M; Meurer T; Poetsch M J Clin Pathol; 2016 Mar; 69(3):204-8. PubMed ID: 26281864 [TBL] [Abstract][Full Text] [Related]
15. Targeted therapies for RET-fusion cancer: Dilemmas and breakthrough. Ding S; Wang R; Peng S; Luo X; Zhong L; Yang H; Ma Y; Chen S; Wang W Biomed Pharmacother; 2020 Dec; 132():110901. PubMed ID: 33125973 [TBL] [Abstract][Full Text] [Related]
16. A Performance Comparison of Commonly Used Assays to Detect RET Fusions. Yang SR; Aypar U; Rosen EY; Mata DA; Benayed R; Mullaney K; Jayakumaran G; Zhang Y; Frosina D; Drilon A; Ladanyi M; Jungbluth AA; Rekhtman N; Hechtman JF Clin Cancer Res; 2021 Mar; 27(5):1316-1328. PubMed ID: 33272981 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Advances in the Management of Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer. Sun F; McCoach CE Curr Treat Options Oncol; 2021 Jun; 22(8):72. PubMed ID: 34165651 [TBL] [Abstract][Full Text] [Related]
18. Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating Rich TA; Reckamp KL; Chae YK; Doebele RC; Iams WT; Oh M; Raymond VM; Lanman RB; Riess JW; Stinchcombe TE; Subbiah V; Trevarthen DR; Fairclough S; Yen J; Gautschi O Clin Cancer Res; 2019 Oct; 25(19):5832-5842. PubMed ID: 31300450 [TBL] [Abstract][Full Text] [Related]
19. Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer. Sartore-Bianchi A; Ardini E; Bosotti R; Amatu A; Valtorta E; Somaschini A; Raddrizzani L; Palmeri L; Banfi P; Bonazzina E; Misale S; Marrapese G; Leone A; Alzani R; Luo D; Hornby Z; Lim J; Veronese S; Vanzulli A; Bardelli A; Martignoni M; Davite C; Galvani A; Isacchi A; Siena S J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563355 [TBL] [Abstract][Full Text] [Related]
20. Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR-mutated NSCLC patients who had progressed on first- or second-generation EGFR TKI. Klempner SJ; Bazhenova LA; Braiteh FS; Nikolinakos PG; Gowen K; Cervantes CM; Chmielecki J; Greenbowe JR; Ross JS; Stephens PJ; Miller VA; Ali SM; Ou SH Lung Cancer; 2015 Sep; 89(3):357-9. PubMed ID: 26187428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]